文献速递重症综合管理与镇静镇痛心脑血管急症

COVID-19重症患者炎症、高凝与巨噬细胞活化临床生物标志物与谵妄的关系

Relationship Among Clinically Obtained Biomarkers of Inflammation, Hypercoagulability, and Macrophage Activation, and Delirium in Critically Ill Patients With COVID-19.
PubMed 文献 · Crit Care Explor · 2023-01-18
一句话结论COVID-19 ICU患者中,d-二聚体和铁蛋白升高与次日谵妄/昏迷复合结局风险增加相关,CRP与次日昏迷及谵妄严重程度相关。

这项回顾性观察性队列研究纳入2020年3月1日至6月7日两家大型城市学术转诊医院ICU收治的197例COVID-19成人患者,每日检测CRP、d-二聚体和铁蛋白,每日两次评估昏迷(Richmond躁动-镇静量表)和谵妄(ICU意识模糊评估法/ICU意识模糊评估法-7)。d-二聚体四分位升高(OR 1.57;95%CI 1.17-2.12;p<0.01)和铁蛋白四分位升高(OR 1.36;95%CI 1.02-1.81;p<0.01)与次日谵妄/昏迷复合结局风险增加相关。CRP四分位升高与次日昏迷(OR 1.36;95%CI 1.03-1.79;p=0.030)和谵妄严重程度(β=0.30;se 0.07;p≤0.01)相关。作者认为这是假设生成性研究,需要更大规模研究验证。

要点

  • 在197例COVID-19 ICU患者中,d-二聚体四分位升高与次日谵妄/昏迷复合结局风险增加相关(OR 1.57;95%CI 1.17-2.12;p<0.01)。
  • 铁蛋白四分位升高与次日谵妄/昏迷复合结局风险增加相关(OR 1.36;95%CI 1.02-1.81;p<0.01)。
  • d-二聚体与次日谵妄(OR 1.49;95%CI 1.14-1.94;p<0.01)和昏迷(OR 1.52;95%CI 1.08-2.14;p=0.017)独立相关。
  • 铁蛋白四分位升高与次日谵妄(OR 1.33;95%CI 1.04-1.70;p=0.026)和昏迷(OR 1.59;95%CI 1.14-2.23;p<0.01)独立相关。
  • CRP四分位升高与次日昏迷(OR 1.36;95%CI 1.03-1.79;p=0.030)及谵妄严重程度(β=0.30;se 0.07;p≤0.01)相关。

适用人群与场景

  • 2020年3月1日至2020年6月7日入住两家大型城市学术转诊医院ICU的所有连续成人COVID-19患者,且进行了临床生物标志物检测和谵妄评估。

研究设计与关键结果

  • 研究类型:回顾性观察性队列研究;场景:两家大型城市学术转诊医院ICU;纳入197例COVID-19 ICU成人患者。
  • 干预:无;每日检测CRP、d-二聚体和铁蛋白浓度,每日两次评估昏迷(Richmond躁动-镇静量表)和谵妄(ICU意识模糊评估法/ICU意识模糊评估法-7)。
  • 主要复合终点:d-二聚体四分位升高与次日谵妄/昏迷复合结局风险增加相关(OR 1.57;95%CI 1.17-2.12;p<0.01);铁蛋白四分位升高与次日谵妄/昏迷复合结局风险增加相关(OR 1.36;95%CI 1.02-1.81;p<0.01)。
  • 独立终点:d-二聚体与次日谵妄独立相关(OR 1.49;95%CI 1.14-1.94;p<0.01),与次日昏迷独立相关(OR 1.52;95%CI 1.08-2.14;p=0.017)。
  • 独立终点:铁蛋白四分位升高与次日谵妄独立相关(OR 1.33;95%CI 1.04-1.70;p=0.026),与次日昏迷独立相关(OR 1.59;95%CI 1.14-2.23;p<0.01)。
  • CRP四分位升高与次日昏迷相关(OR 1.36;95%CI 1.03-1.79;p=0.030),与次日谵妄严重程度相关(β=0.30;se 0.07;p≤0.01)。

证据类型、等级与局限

  • 证据类型:回顾性观察性队列研究;作者称其为假设生成性研究。
  • 局限:作者指出需要更大规模的研究来验证这些结果。

对床旁实践的改变

  • 作者认为该假设生成性研究提示d-二聚体和铁蛋白与次日谵妄/昏迷相关,CRP与次日昏迷及谵妄严重程度相关;需要更大规模研究验证这些结果。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

UNLABELLED: Critically ill patients with COVID-19 experience high rates of delirium and coma. Whether delirium occurs through novel mechanisms in COVID-19 is not known. We analyzed the relationship among biomarkers of inflammation (C-reactive protein [CRP]), hypercoagulability (d-dimer), and lung macrophage activation (ferritin), and the primary composite outcome of delirium/coma next day. We also measured associations between biomarkers and next day delirium and coma independently, and delirium severity.

DESIGN: Retrospective, observational cohort study.

SETTING: ICUs at two large, urban, academic referral hospitals.

PATIENTS: All consecutive adult patients admitted to the ICU from March 1, 2020, to June 7, 2020, with COVID-19 with clinical biomarkers and delirium assessments performed.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: Daily concentrations of CRP, d-dimer, and ferritin were obtained. Coma (assessed by Richmond Agitation-Sedation Scale) and delirium (assessed by Confusion Assessment Method for the ICU/Confusion Assessment Method for the ICU-7) were measured bid. A cohort of 197 ICU patients with COVID-19 were included. Higher d-dimer (odds ratio [OR], 1.57; 95% CI, 1.17-2.12; p < 0.01) and ferritin quartiles (OR, 1.36; 95% CI, 1.02-1.81; p < 0.01) were associated with greater odds of the composite outcome of delirium/coma next day. d-dimer was associated with greater odds of next day delirium (OR, 1.49; 95% CI, 1.14-1.94; p < 0.01) and coma independently (OR, 1.52; 95% CI, 1.08-2.14; p = 0.017). Higher ferritin quartiles were associated with greater odds of next day delirium (OR, 1.33; 95% CI, 1.04-1.70; p = 0.026) and coma independently (OR, 1.59; 95% CI, 1.14-2.23; p < 0.01). Higher CRP quartiles were associated with coma (OR, 1.36; 95% CI, 1.03-1.79; p = 0.030) and delirium severity the next day (β = 0.30; se, 0.07; p ≤ 0.01).

CONCLUSIONS: Our hypothesis-generating study found d-dimer and ferritin were associated with delirium/coma the following day, as well as delirium and coma independently. CRP was associated with next day coma and delirium severity. Larger studies to validate these results are needed.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Khan SH, Perkins AJ, Chi R, et al. Relationship Among Clinically Obtained Biomarkers of Inflammation, Hypercoagulability, and Macrophage Activation, and Delirium in Critically Ill Patients With COVID-19. Crit Care Explor. 2023. PMID: 36699256. doi:10.1097/CCE.0000000000000851

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。